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Highlights 
 A DCE to collect diabetic patient preferences for SDM across countries is proposed. 
 This is the first application of a DCE survey to value patient care in Cyprus.  
 People with diabetes do value SDM.  
 Different SDM models may fit different settings and patient experiences. 
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Title: Implementing shared-decision-making for diabetes care across country settings: what really 
matters to people? 
Abstract 
Context: Growing evidence of improved clinical outcomes and patient/professional satisfaction 
supports shared-decision-making (SDM) services as an effective primary care interventions for 
diabetes. However, only a few countries have actually adopted them (e.g. England). In other European 
countries (e.g. Cyprus) there is awareness that patients play a crucial role in decision-making, and SDM 
services could be considered as innovative strategies to promote the actual implementation of patient 
rights legislation and strengthen primary care.  
Objective: to understand preferences of people with diabetes when choosing their care, and how they 
value alternative SDM services compared to their ‘current’ option. Preferences were collected from 
patients based in England, where SDM is already in place at national level, and Cyprus, where people 
are new to it, using a discrete-choice-experiment (DCE) survey.  
Results: Cypriots valued choosing alternative SDM services compared to their ‘current’ option, 
whereas the English preferred their status quo to other services. Having the primary-care-physician as 
healthcare provider, receiving compassionate care, receiving detailed and accurate information about 
their care, continuity of care, choosing their care management and treatment, and reduced waiting 
time were the SDM characteristics that Cypriots valued; the English preferred similar factors, apart 
from information/continuity of care.  
Conclusion: People with diabetes do value SDM and different SDM models may fit different groups 
according to their personal experience and country specific settings. 
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Background 
Shared-decision-making (SDM) requires a partnership between patients and professionals, working 
together to select tests, treatments and support packages of care based on patient preferences and 
patients’ needs, clinician experience and research evidence.  It can improve people’s engagement in 
healthcare and help the delivery of effective services.1 although there is limited evidence from 
randomised controlled trials to show improved clinical outcomes for diabetes care with SDM use, 
there is research (mainly looking at patient and professional satisfaction) supporting SDM as an 
effective intervention for long-term conditions, such as diabetes.1-3  Its implementation is often 
discussed in health and social sciences and successful case studies are available from Northern Europe 
and the overseas contexts.2 Research evidence suggests that the most effective strategies may 
include: decision aids of various types; action plans and goal setting; structured one-to-one or group 
support for patients; training to enhance the skills of professionals.2  
 
In England SDM is embedded in the National Health Service (NHS) Constitution and the NHS Mandate.4 
The NHS Constitution states that ‘we have the right to full information about treatment options, and 
to participate in decisions’. The Mandate includes an objective ‘to ensure the NHS becomes 
dramatically better at involving patients and their caregivers, and empowering them to manage and 
make decisions about their own care and treatment.’ In order to support developments in this area, a 
Shared Decision Making Collaborative has been established in 2015. It comprises members from the 
statutory sector, patient and voluntary sector organisations and academia committed to thinking 
collectively about the role of SDM in UK health systems.4-5 Their recommendations describe a multi-
component approach based on seven factors: leadership and culture change; local leadership, 
education and training, shared decision making tools, guidance development and evidence reviews, 
measurements of successful shared decision making and research. Taken together, these factors 
would aim at encouraging a shift in England heath care delivery to SDM services. 
In other European countries there is awareness that patients play a crucial role in decision-making, 
and SDM practices could be considered as innovative strategies to promote patient rights6 and support 
the development of a framework for action towards people-centred health services delivery.7 
Although most research on SDM in Europe has occurred in Northern European countries, the SDM 
model fits also within the priorities of the Mediterranean region, to include: the improvement of 
health literacy, the improvement of patient provider communication, and the empowerment of 
individuals to be more involved in their healthcare.8 To our knowledge, discussion about its 
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development in the Mediterranean region and Cyprus is limited. The case study of diabetes care offers 
examples of good SDM practices at international level and can provide common ground for developing 
a SDM framework to fit the needs of a series of European settings and the management of alternative 
chronic conditions.2-3 More specifically this project will cover two countries, England and Cyprus. 
These two countries at the edges of Europe, have been both hit by the economic crisis in different 
ways and to different extents, and their health care systems are now facing severe consequences with 
direct impact on the delivery of diabetes care.9 It is important to underline that in Cyprus the Public 
Health Care system was implemented when the country was part of the British Empire, and as such, 
its philosophy resembles NHS. Nevertheless, due to lack of a universal coverage Health System, only 
marginal reforms occurred. This is imputed to an extended anticipation of the National Health System 
which is perceived to be a deus ex machina for the efficiency enhancement of Health Care Sector.   As 
a result, all major health reforms, are scheduled to occur once the NHS is implemented.10 Interestingly, 
introduction of NHS has been postponed for late 2018, thus prolonging uncertainty and perpetuating 
inertias of the system.  The situation is further aggravated in Cyprus; after being pushed to the verge 
of bankruptcy, this country is now facing radical healthcare reforms toward the implementation of a 
new scheme of Health Insurance.11-12 The British and Cypriot case studies report also on different 
experience of diabetes care. In the former SDM is already in place at a national level, and we can draw 
from people direct experience2; in the latter people are new to it, although there could be room for 
future implementation. There is already evidence that Cypriot patients, their carers and health care 
professionals are prepared to welcome new diabetes management models able to promote patient 
autonomy and self-management, and closer relationship between patient and health care 
professional.13-14 
This study aimed at understanding patients’ preferences when choosing health care services for their 
diabetes care, and how they value SDM, as a process in which healthcare professionals and patients 
work together to select tests, treatments, management, or support packages, based on clinical 
evidence and patients’ informed preferences. Results allowed to estimate the components of SDM 
that people value, their relative importance; but also the potential participation rates to SDM 
programmes. 
Methods 
Participants, recruitment and data collection 
We involved a convenient sample of primary care sites in each country to act as participant 
recruitment sites, from which a purposive sample of people with diabetes was drawn.  
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The research team approached about 150 participants from each country; assuming a 70% 
recruitment rate, and 30% attrition rate (i.e. incomplete questionnaire or inconsistent responses in 
questionnaire), the final sample size included 51 respondents in England and 90 respondents in Cyprus 
with completed questionnaires suitable for analysis. This followed current guideline for discrete 
choice experiment questionnaire.15 
Participants were eligible for the study if they were: seeking care for their diabetes; aged 18 years or 
more; and able to read and understand English and Greek (in Cyprus). In order to facilitate data 
collection form the Cypriot sites, Greek copy of the questionnaires were made available as necessary. 
Participants were excluded if they: did not agree to complete the questionnaire; appeared to be too 
physically or mentally unwell to approach based on the practice staff’s judgment; or were in clinic to 
assist another patient who is seeking care. 
Potential participants were approached by clinic staff when attending the clinic for their visits. 
Completed questionnaires were collected by a member of the practice staff, and sent to the research 
team.  If patients felt that the time at the clinic was not sufficient for them to read the information 
sheet and complete the questionnaire, they were given the opportunity to complete the questionnaire 
at home and return it to the research team via post using a reply-paid envelope. To better enable 
participants to complete the questionnaire alone, an example question was presented in the material 
(Supplementary Material Figure 1). Ethical approval was granted by the London School of Economics 
Research Ethics Committee, the Health Research Authority in England (13/NW/0893), the Ministry of 
Health in Cyprus, the Cyprus Bioethics Committee and the Cyprus Office of Commission for the 
Protection of Personal Data. Data collection took place between May and September 2014. 
Discrete choice experiment 
A Discrete Choice Experiment (DCE) questionnaire was distributed to diabetes patients to value 
patient preferences for SDM compared with current care. DCE is a quantitative technique for eliciting 
individual preferences.16-17 It is becoming a frequently used tool in international clinical practice 
research to estimate the average participation rates of healthcare interventions and to provide 
knowledge about the components of the interventions that determine the participation rates. Their 
application to develop and value healthcare interventions has been reported across healthcare 
settings and conditions16-17-18, including diabetes care.19 There is no publication of their use to inform 
health service development comparing patient experiences from Northern to Southern Europe 
nations.  
Attributes and levels 
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The attributes and levels included in the current study were determined in a stepwise manner, which 
subsequently covered a literature review, clinician interviews and field testing with patients and their 
representatives. First, a list of characteristics for describing SDM practices in diabetes patients was 
compiled based on previously published literature20. Second, the list of SDM characteristics was 
discussed during expert interviews with a physicians (GPs) and nurses (diabetes-specialist-nurses, 
DSNs) and clinicians with a specific interest in diabetes care based both in England and Cyprus (7 
overall). These expert interviews were conducted in order to shorten the list of potential attributes 
and to ensure that the attributes and levels were consistent with current practice in both countries. A 
third step, testing with patients was conducted in order to ensure that the most important attributes 
for the decision-making process of people with diabetes were included in the DCE and proper levels 
were used to each of the attributes as well as its length, its ability to be completed, and need for 
additional questions or possible rewording. No changes in the attributes and/or levels were deemed 
necessary based on the feedback received from discussion with 8 patients from both countries.  
The DCE questionnaire collected information on: patient preferences for alternative SDM services 
(defined by the set of attributes and levels emerging from the stepwise approach described above) vs. 
usual care (using a DCE set of choices); their experience in seeking care; and their socio-demographic 
characteristics.  
DCE choice design  
Based on the selected attributes and levels, NGene (ChoiceMetrics, 2011) software was used to 
develop a D-efficient design with 12 unique choice tasks. To limit the burden of respondents, we 
divided these 12 choice tasks over three sets of four choice tasks, each set of DCE tasks was 
disseminated among a third of the study population. Besides choosing between two different 
combinations of healthcare services, participants could also choose to opt-out and prefer their current 
care. This opt-out option was included because, in real life, people can also choose not to receive an 
alternative diabetes care to the one they are currently receiving. A summary of DCE attributes, levels 
and regression coding. The attributes and levels that were included in this DCE are reported in 
Supplementary Material Table 1. 
Statistical analyses 
NLogit 4.0 (Econometric Software, 2007) was used to construct the econometric models that were 
estimated within this study. When analysing responses to multiple-choice DCE survey, typically the 
multinomial logit (MNL) model is used, although there is growing application of alternative models 
when relaxing its assumptions. MNL was compared with alternative mixed logit models to allow for 
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unobserved heterogeneity across individuals.15 Based on measure of the relative quality of statistical 
models for a given set of data (Akaike information criterion (AIC) and log-likelihood ratio index (LLRI)) 
The preferred conditional logit model is presented here:  
Uji = Vji  + eji            Eq 1   
Where    
Vji = constant alternative service + β 1 INFO1 + β 2 INFO2 + β 3 INFO3 + β 4 COMPASSION1 + β 5 COMPASSION2 
+ β 6 COMPASSION3 + β 7 MANAGMENT1 + β8 MANAGMENT2 + β 9 MANAGMENT3 + β 10TIME1 + β 
11CONTINUITY1 + β 12PROVIDER1 + β 13PROVIDER2 + β 14PROVIDER3 + β 15PROVIDER4  Eq 2  
  Uij = the utility of the jth choice to the ith individual, Vij is the systematic part of the utility function 
observable by the researcher and eji is the error term.     
Vij describes the measurable utility of (preference for) an alternative SDM practice j for individual i 
based on the attributes that were included in the DCE. For analysis, the reference alternative was the 
‘current’ option. The constant alternative_service estimated the utility of (preference for) moving, to an 
alternative healthcare service rather than staying with the ‘current’ option.  
β1 – β15 are the attribute estimates that indicate the relative importance of each attribute.  
The DCE results allowed to identify what characteristics of the service respondents value (for example 
they could value ‘choosing treatment options, and managing care’, reducing their ‘waiting time’ rather 
than other aspects) and the relative values that they attach to these (for example they could value 
‘being involved in decision about the management of their care and treatment’ more than other 
aspects). In order to calculate patients’ marginal willingness to wait, the negative of the time attribute 
was used as a measure of the marginal utility of time. The ratio of either attribute estimate to this 
negative of the time attribute provides an estimation of patients’ willingness to wait in the community 
care site for a unit change in that specific attribute (e.g. willingness to wait to ‘receive continuity of 
care’). In addition, expected participation rates (choice probabilities) to alternative SDM services were 
calculated compared with ‘current’ option. Explanation of the alternative SDM services 1-2 is 
presented in table 1. 
Results  
Responses 
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Data came from community sites in England (51 respondents from two primary care physician sites) 
and Cyprus (90 respondents, from three primary care physician sites (46) and one diabetes specialist 
clinic in hospital providing community services to diabetes patients, 44). Both country-specific samples 
presented comparable socio-demographic characteristics, apart from age (p<0.01), overall health 
state (p<0.01) and comorbidities (p<0.01) (see table 2).  
Current experience of care  
In both countries the majority of patients received information about their care (most of the 
times/always; 93% Cyprus, 86% England); compassionate care (93.3% Cyprus; 86.3% England); 
continuity of care (93.3% Cyprus; 58.8% England; see Figure 1). In Cyprus the majority of patients were 
involved in decision about the management of their care only (75.6%), whilst in England they were 
involved in decision about both the management of their care and treatment options (58.8%). In 
Cyprus patients had to wait one hour or more for their visit (82.2%), whilst in England they experienced 
shorter waiting time (less than 1 hour 68.6%). In Cyprus the majority of patients received care from 
primary care physician and hospital diabetes clinic (54.4%) or primary care physician and nurse 
(40.0%), whilst in England the respondents had experience of receiving care from primary care 
team/GP only (71%). For all attributes the difference between Cyprus and England groups was 
statistically significant at 1%. 
Preferences about their care 
The results from the DCE model are presented in Supplementary Material Table 2. A few of the 
attribute estimates were significant, indicating that they are important for people with diabetes when 
choosing about their healthcare. Scaling factor issues did not allow a direct comparison of parameter 
estimates across groups.15 Willingness to wait estimates (see Figure 2) were employed for such 
comparisons. They were calculated for the significant attributes only. 
Cypriot respondents valued the opportunity to choose alternative healthcare services compared to 
their ‘current’ option (they were willing to wait extra 2 more hours to be able to receive alternative 
service to their ‘current’ option with everything else constant). When choosing their care they prefer 
(in order of importance): 
1. Care provider – they were willing to wait 8 more hours to ‘receive care from GP only’ rather 
than from staff at the diabetes centre in the hospital; 
2. Compassion - they were willing to wait 8 more hours to ‘receive always care and compassion 
for their personal situation’; 
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3. Information - they were willing to wait 6-7 more hours to ‘receive most of the times/always 
detailed and accurate information about their care’; 
4. Continuity of care - they were willing to wait 5 more hours to receive care from the same 
healthcare provider(s); 
5. Care management and treatment - they were willing to wait almost 4 more hours to ‘choose 
treatment options and manage their care’; 
They least valued attribute was ‘waiting time’. 
English respondents preferred their ‘current’ option compared with alternative community care 
services. When choosing their care they valued fewer characteristic compared with Cypriot 
respondents and they were (in order of importance): 
1. Care provider - they were willing to wait 2 more hours to ‘receive care from their GP compared 
with hospital specialist only’; 
2. Compassion – they were willing to wait almost 2 more hours to ‘receive sometimes 
compassionate care’; 
3. Care management and treatment – they were willing to wait about one more hour to manage 
their care (either in association with choosing their treatment or alone). 
They also valued reducing their waiting time, whereas other aspects of care important to Cypriot 
respondents, such as receiving detailed and accurate information about their care, or receiving 
continuity of care, were not important to them. 
When comparing willingness to wait estimates across groups (see Figure 2) it appeared that Cypriot 
respondents valued more SDM care compared English respondents, characterized by: ‘receiving 
always detailed and accurate information about your care’ or ‘continuity of care’ (valued by Cypriots 
7.34 and 4.90 hours respectively, whereas the English reported them as not important); 
‘compassionate care’ (8.10 vs. 0.13 hours, Cypriot and English respondents respectively); or ‘being 
involved in care management and choice of treatment option’ (3.72 vs. 1.10 hours). Everything else 
constant, Cypriot patients valued more an alternative SDM compared with their current, whereas 
English patients preferred their current experience to other services. Differences between groups 
were statistically significant at 1%. 
Expected participation rates and policy analysis 
Two different scenarios were considered and they are fully explained in Table 1.  
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The most preferred SDM service (best scenario, alternative SDM service 2), which includes ‘always’ 
detailed and accurate information about their care’, ‘always’ care and compassion for their personal 
situation’, ‘choosing their treatment options, and manage their care’, 50% decrease in their ‘waiting 
time’ and ‘receiving care from the GP/physician only’, resulted in an estimated potential participation 
rate of 90.08% in Cyprus and 52.39% in England (compared with ‘current’ option; p<0.01).  
Discussion 
Main findings 
This study demonstrates the complexity of patient decision making processes regarding their care for 
diabetes in community setting. Our findings suggested that people with diabetes value SDM services 
although the importance of the service features may change across healthcare systems. Cypriot 
patents valued choosing alternative SDM services compared to their ‘current’ option, whereas English 
respondents preferred their status quo (where they had already experience of SDM and shorter 
waiting times). Receiving support from the ‘primary physician’, ‘compassionate care’, ‘detailed and 
accurate information about their care’, ‘continuity of care’, ‘choosing their care management and 
treatment’, and reduced ‘waiting time’ were the service characteristics that Cypriots valued mostly; 
the English preferred similar factors, apart from ‘detailed and accurate information about their care’ 
or ‘continuity of care’ that were not valued. Participation rates to alternative SDM services to their 
‘current’ option ranged between 47-90% in Cyprus and 43-52% in England.  
Comparison with other studies 
Results from a recent DCE experiment looking at estimating the relative importance of organisational, 
procedural, and interpersonal characteristics of healthcare delivery systems from the patient 
perspective showed that elements such as SDM were considered as the most important across country 
settings.21 Receiving support from their GP was one of the most important variables to explain 
satisfaction among primary care patients across groups and this is confirmed by recent data in 
Europe.22   
Compassionate care23-24 was also reported an important factor in helping patient managing their 
chronic condition in England, as well as self-management, decreased waiting time and receiving care 
from primary care provider.25 Access to information and continuity of care did not appear to be 
important factors associated to patient satisfaction; although there is evidence in England that 
patients do value them,26-27 there are also papers arguing that for example continuity of care is not 
valued by all patients or across all settings (for example see 28). Findings from the Cypriot case study 
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also substantiate previous studies in the country29-30 which concluded that patients are satisfied with 
outpatient services provided by both private and public sectors. They also reported that for patients 
SDM is a necessity and not an option and should be embedded within the Cyprus health care 
framework. 
Strengths, limitations and future work 
The added value of this study is that this is the first application of a DCE survey to value patient care 
in Cyprus and compare information on what aspects of care are important to patients. But also it 
allows to calculate trade-off between them, and value the benefit for policy changes vs other 
healthcare system in England. Cyprus health care system, largely a legacy from the English colonial 
era, has exceeded its functional capacity and the need to move forward is imperative. This study offers 
a new and largely unexplored insight on what people actually value; importantly this enriches the 
policy framework in Cyprus, since is the first study to address patient preferences. These findings could 
serve as a benchmark in the design phase of the NHS and by capitalising on these performance 
indicators it is feasible that a patient-centred and more efficient system can be developed. Moreover, 
by using patient preferences to inform policy change, a mutual consensus by stakeholders is more 
likely to occur. This would allow to relieve tensions that have accumulated due to delays in the 
introduction of NHS and consequent protracted inconvenience of patients.31 The current 
fragmentation of health sector in Cyprus between public (virtually the only sector where people with 
diabetes can receive care from a limited number of multidisciplinary teams) and private (where care 
is delivered by physicians only) can explain the significance difference regarding the participation rates 
(47% for multidisciplinary care, 90% for care delivered by physician only). Capitalising on these 
findings, Cyprus health authorities-even prior to the introduction of NHS- can gradually shift into a 
patient-centred health care, which does not assume significant financial burden. Parameters such 
as providing compassionate care’ or detailed and accurate information stem out of health care 
professionals' role. Indeed, health care professionals can be trained to address such aspects in the 
consultation with their patients; this could be easily carried out through awareness and targeted 
education initiatives (see examples in England).32-34 To this direction, a pivotal work - embedded within 
the EU funded EUBIROD project (European best information through regional outcomes in diabetes; 
http://www.eubirod.eu/) - was introduced in Cyprus diabetes hospital clinic aiming to incorporate 
SDM into clinical practice. Early unpublished data indicate positive impact on patient’s compliance, 
satisfaction and engagement while an improved glycaemic control was also observed. On the contrary, 
the English NHS due to its constant and relentless reforms offers value to patients and constitute a 
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key example of SDM as good clinical practice that can improve value and cost-effectiveness35 and can 
be used to inform a policy shift to SDM in Cyprus within the forthcoming new NHS. 
Specific lessons for Cypriot policy makers and the new NHS that is under development may include:  
Fostering SDM in chronic disease management could have a positive impact on patients satisfaction 
and probably also in disease outcomes; training of the healthcare professionals and the patients on 
SDM, its benefit and its practical implementation would be needed to support the implementation of 
SDM in the country; developing a country specific guideline for SDM could be beneficial to 
institutionalise the SDM model in the NHS; the SDM evaluation tool proposed in this paper could be 
further developed and applied as useful approach in evaluating the quality of healthcare service and 
SDM provision under the reformed system. This paper presents the comparison between public 
providers in England (based in GP practices) and Cypriot public sites including both primary care 
practices (primary care physicians and practice nurses) and hospital settings (staff from a hospital-
based diabetes clinic and practice). Due to time and budget constraints data from hospital-based 
diabetes clinics in England are missing from the comparison. More work would be needed to 
investigate patient and clinician experiences across healthcare settings in the different countries. 
Crucially the DCE-based model presented here does appear to be a successful framework to capture 
patient preferences for diabetes care and it could also be used as springboard for a much needed 
larger scale evaluation of stakeholder preferences in the Mediterranean area when applying SDM 
processes to the management of diabetes and other chronic diseases. 
Conclusion: Policy decision making requires consideration of patient preferences and, moreover, the 
information on preferences can be used to develop effective delivery of diabetes care.  People with 
diabetes do value SDM and different SDM models may fit different groups according to their personal 
experience and country specific health care systems. 
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Figure 1:  Current care 
 
Note: Differences between Cyprus and England groups were statistically significant at 1%. 
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Figure 2: Willingness to wait results 
 
Note: Willingness to wait results were calculated only for the service characteristics that were significant results at 10% (see Supplementary Material Table 
2).  Differences between Cyprus and England groups were statistically significant at 1%.  
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Table 1: Expected participation rates (choice probabilities) for different SDM services based on the attribute estimates of the DCE results 
Alternative 
model  
Cyprus 
Participation rate %  
England 
Participation rate % 
P value  
 
Explanation 
Alternative 
SDM service 1 
47.42  43.43 0.45 The alternative SDM service 1 presents: ‘always’ detailed and 
accurate information about their care; ‘always’ care and compassion 
for their personal situation; ‘choosing their treatment options, and 
manage their care’; 50% decrease in their ‘waiting time’; ‘receiving 
care from the same provider(s)’; receiving care from GP, hospital 
specialist and nurse (Primary care physician, hospital 
physician/specialist, and nurse, in Cyprus) (alternative scenario with 
the most preferred attribute levels apart from who is providing 
care). 
Alternative 
SDM service 2 
90.08  52.39 0.01 The alternative SDM service 2 presents: ‘always’ detailed and 
accurate information about their care’; ‘always’ care and 
compassion for their personal situation’; ‘choosing their treatment 
options, and manage their care’; 50% decrease in their ‘waiting 
time’; ‘receiving care from the GP/physician only’ (best scenario with 
the most preferred attribute levels). 
Note: Expected participation rates were calculated by using the following formula: Pc (alternative diabetic service 1) = exp (V1n)/Σj exp Vjn, where 
individual n will choose alternative diabetic service 1 within a choice set C of J (j = 1, ... , J) options. 
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Table 2: Responses, patient characteristics  
  
Cyprus  
 
England 
 
 
  no. % no. % P value* 
Sites 
GP (primary care 
physician) sites 46 51 51 100 
 
 Hospital diabetic clinic 44 49 n/a   
 Total 90  51   
Blocks 
 
 
1 28 31.1 17 33.3 0.84 
2 28 31.1 12 23.5  
3 34 37.8 22 43.1  
What age are you 
on your next 
birthday?  Mean (sd) 59.32 16.3 69.16 11.6 
<0.01 
Gender 
Male 37 48.1 26 54.2 0.50 
Female 40 51.9 22 45.8  
How would you 
describe your 
overall health on 
a 0-5 scale 
ranging from very 
poor to excellent 
Very poor 0 0 0 0 <0.01 
Poor 1 1.2 5 10.4  
Average 17 19.8 18 37.5  
Good 55 64.0 17 35.4  
Very good 13 15.1 8 16.7  
No. of years with 
diabetes   12.84 9.7 10.85 3.25 
0.16 
Have you been 
diagnosed with 
any of these 
other illnesses? 
Cancer 4 4.4 9 16.7 <0.01 
Heart disease 14 15.4 7 13.0  
Asthma 3 3.3 3 5.6  
Other 5 5.5 11 20.4  
No co-morbidities/ 
missing data 65 71.4 24 44.4 
 
In paid work 24 27.3 9 20 0.63 
Unemployed 4 4.5 0 0  
21 
 
What best 
describes your 
current situation 
Retired from paid 
work 
45 51.1 
32 71.1 
 
Unable to work 
because of disability 
1 1.1 
3 6.7 
 
Looking after family, 
home, or dependents 
8 9.1 
1 2.2 
 
In full-time education 4 4.5 0 0  
Others  2 2.3 0 0  
*Anova test for independent groups 
 
 
Supplementary Material Figure 1: An example of DCE choice question 
 
 Service A Service B 
Detailed and accurate 
information about your care 
Rarely/never 
 
Always 
 
Care and compassion for your 
personal situation 
Most of the time 
 
Sometimes 
 
Choosing your treatment options, 
and manage your care 
I can only manage my care I can only manage my 
care 
Waiting time at the clinic 2 hours 2 hours 
Care from the same GP, nurse,  
specialist doctor, or team of 
professionals  
Yes 
 
No 
 
Who is providing your care Hospital specialist only 
(Hospital physician/ 
specialist only, Cypriot 
version) 
GP and nurse 
(Primary care physician 
and nurse, Cypriot 
version) 
Which service would you choose? I choose Service A 
 
□ 
I choose Service B 
 
□ 
I choose My 
current Service* 
□ 
a Information on ‘current’ situation was collected from each individual within the DCE. 
  
Supplementary Material Table 1: DCE attributes, levels and regression coding 
ATTRIBUTES LEVELS [REGRESSION CODING] 
1) Information 
[receiving detailed and 
accurate information about 
their care] 
- Always [INFO3] 
- Most of the times [INFO2] 
- Sometime [INFO1] 
-Rarely/never a 
2) Compassion 
[receiving care and 
compassion for their 
personal situation] 
- Always [COMPASSION3] 
- Most of the times [COMPASSION2] 
- Sometime [COMPASSION1] 
-Rarely/never a 
3) Care management  
[choosing treatment 
options, and managing care] 
- I can choose my treatment options and manage my care [MANAGMENT3] 
-  I can only choose my treatment options [MANAGMENT2] 
- I can only manage my care [MANAGMENT1] 
- None of them a 
4) Waiting time 
[waiting time at the site] 
 
- Less than 1 hour a 
- 1 hour [TIME1] 
- 2 hours [TIME2] 
- 3 hours or more [TIME3] 
5) Continuity of care 
[receiving community care 
from the same GPb 
/nurse/specialist doctor] 
- Always [CONTINUITY3] 
- Most of the times [CONTINUITY2] 
- Sometime [CONTINUITY1] 
-Rarely/never a 
6) Who is providing care 
 
- GP only (Primary care physician only, in Cyprus) a 
- GP and nurse (Primary care physician and nurse, in Cyprus) [PROVIDER1] 
- Hospital specialist only (Hospital physician/specialist only, in Cyprus) 
[PROVIDER2] 
- Hospital specialist and nurse (Hospital physician/specialist and nurse, in 
Cyprus) [PROVIDER3] 
- GP, hospital specialist and nurse (Primary care physician, hospital 
physician/specialist, and nurse, in Cyprus) [PROVIDER4] 
Alternatives - Alternative community care service [ALTERNATIVE_SERVICE] 
- ‘Current’ situation a 
a Reference level; b Primary care physician in Cyprus 
  
Supplementary Material Table 2: DCE results  
 
 
 
 Cyprus  
 
England  
 
 Coeff. SE P-val Coeff. SE P-val 
HEALTHCARE SERVICE CHARACTERISTICS 
Information [receiving detailed and accurate information about their care] 
(Compared to  Rarely/never)       
Sometimes 1.61 1.04 0.12 0.50 0.93 0.58 
Most of the times 2.13 0.83 <0.01 0.03 0.54 0.94 
Always 1.73 0.64 <0.01 0.16 0.47 0.72 
Compassion [receiving care and compassion for their personal situation] 
(Compared to  Rarely/never)       
Sometimes -0.63 0.91 0.48 -1.59 0.84 0.16 
Most of the times 1.41 0.92 0.12 0.49 0.54 0.36 
Always 2.35 0.84 <0.01 0.13 0.53 0.04 
Care management [choosing treatment options, and managing care] 
(compared to none of them)       
I can choose my treatment options and 
manage my care 
1.08 0.58 0.06 1.07 0.61 0.07 
 
I can only choose my treatment options 0.21 0.96 0.82 -0.65 0.62 0.29 
I can only manage my care 0.93 0.64 0.14 0.95 0.51 0.06 
Waiting time [waiting time at the site] 
 -0.29 0.25 0.05 -0.97 0.24 <0.01 
Continuity of care [receiving community care from the same GP ( Primary care physician in Cyprus) 
/nurse/specialist doctor] 
(Compared to  Rarely/never)       
yes 1.42 0.58 <0.01 0.04 0.32 0.90 
Who is providing care 
(Compared to GP only in England; Primary 
care physician only, in Cyprus) 
      
GP and nurse  in England (Primary care 
physician and nurse, in Cyprus) 
0.55 0.85 0.51 0.24 0.55 
 
0.66 
Hospital specialist only  in England (Hospital 
physician/specialist only, in Cyprus) 
-1.98 1.43 0.16 -1.91 0.98 0.05 
Hospital specialist and nurse  in England  
(Hospital physician/specialist and nurse, in 
Cyprus) 
-2.43 1.25 0.05 -0.98 0.63 
 
0.12 
GP, hospital specialist and nurse  in England  
(Primary care physician, hospital 
physician/specialist, and nurse, in Cyprus) 
-1.21 .90 0.17 -0.36 0.93 
 
0.69 
 
ALTERNATIVES 
(compared to current)       
Alternative community care service 0.64 0.36 0.07 -1.13 0.40 <0.01 
No of observations 351 203 
No of individuals 90 51 
